KRas-LCS6 polymorphism does not impact on outcomes in ovarian cancer

by Caiola, Elisa, Rulli, Eliana, Fruscio, Robert, Buda, Alessandro, Broggini, Massimo, Marabese, Mirko
Published 2012

Assessment of proportional hazard assumption in aggregate data: a systematic review on statistical methodology in clinical trials using time-to-event endpoint

by Rulli, Eliana, Ghilotti, Francesca, Biagioli, Elena, Porcu, Luca, Marabese, Mirko, D’Incalci, Maurizio, Bellocco, Rino, Torri, Valter
Published in Br J Cancer (2018)

Vision-related quality of life and symptom perception change over time in newly-diagnosed primary open angle glaucoma patients

by Riva, Ivano, Legramandi, Lorenzo, Rulli, Eliana, Konstas, Anastasios G., Katsanos, Andreas, Oddone, Francesco, Weinreb, Robert N., Quaranta, Luciano
Published in Sci Rep (2019)

Author Correction: Vision-related quality of life and symptom perception change over time in newly-diagnosed primary open angle glaucoma patients

by Riva, Ivano, Legramandi, Lorenzo, Rulli, Eliana, Konstas, Anastasios G., Katsanos, Andreas, Oddone, Francesco, Weinreb, Robert N., Quaranta, Luciano
Published in Sci Rep (2020)

The 5′UTR variant of ERCC5 fails to influence outcomes in ovarian and lung cancer patients undergoing treatment with platinum-based drugs

by Rulli, Eliana, Guffanti, Federica, Caiola, Elisa, Ganzinelli, Monica, Damia, Giovanna, Garassino, Marina C., Piva, Sheila, Ceppi, Lorenzo, Broggini, Massimo, Marabese, Mirko
Published in Sci Rep (2016)

Visual field loss and vision-related quality of life in the Italian Primary Open Angle Glaucoma Study

by Rulli, Eliana, Quaranta, Luciano, Riva, Ivano, Poli, Davide, Hollander, Lital, Galli, Fabio, Katsanos, Andreas, Oddone, Francesco, Torri, Valter, Weinreb, Robert N.
Published in Sci Rep (2018)

Author Correction: Visual field loss and vision-related quality of life in the Italian Primary Open Angle Glaucoma Study

by Rulli, Eliana, Quaranta, Luciano, Riva, Ivano, Poli, Davide, Hollander, Lital, Galli, Fabio, Katsanos, Andreas, Oddone, Francesco, Torri, Valter, Weinreb, Robert N.
Published in Sci Rep (2020)

Impact of ERCC1, XPF and DNA Polymerase β Expression on Platinum Response in Patient-Derived Ovarian Cancer Xenografts

by Guffanti, Federica, Alvisi, Maria Francesca, Caiola, Elisa, Ricci, Francesca, De Maglie, Marcella, Soldati, Sabina, Ganzinelli, Monica, Decio, Alessandra, Giavazzi, Raffaella, Rulli, Eliana, Damia, Giovanna
Published in Cancers (Basel) (2020)

Latanoprost and Dorzolamide for the Treatment of Pediatric Glaucoma: The Glaucoma Italian Pediatric Study (Gipsy), Design and Baseline Characteristics

by Quaranta, Luciano, Biagioli, Elena, Galli, Francesca, Poli, Davide, Rulli, Eliana, Riva, Ivano, Hollander, Lital, Katsanos, Andreas, Longo, Antonio, Uva, Maurizio G., Torri, Valter, Weinreb, Robert N.
Published in Adv Ther (2016)

Chemotherapy versus erlotinib as second-line treatment in patients with advanced non-small cell lung cancer and wild-type epidermal growth factor receptor: an individual patient da...

by Garassino, Marina Chiara, Kawaguchi, Tomoya, Gregorc, Vanesa, Rulli, Eliana, Ando, Masahiko, Marsoni, Silvia, Isa, Shun-ichi, Novello, Silvia, Farina, Gabriella, Barni, Sandro, Torri, Valter, Cinquini, Michela
Published in ESMO Open (2018)

Prognostic value of CT integrated with clinical and laboratory data during the first peak of the COVID-19 pandemic in Northern Italy: A nomogram to predict unfavorable outcome

by Angeli, Enzo, Dalto, Serena, Marchese, Stefano, Setti, Lucia, Bonacina, Manuela, Galli, Francesca, Rulli, Eliana, Torri, Valter, Monti, Cinzia, Meroni, Roberta, Beretta, Giordano Domenico, Castoldi, Massimo, Bombardieri, Emilio
Published in Eur J Radiol (2021)

Digital Immunophenotyping Predicts Disease Free and Overall Survival in Early Stage Melanoma Patients

by De Logu, Francesco, Galli, Francesca, Nassini, Romina, Ugolini, Filippo, Simi, Sara, Cossa, Mara, Miracco, Clelia, Gianatti, Andrea, De Giorgi, Vincenzo, Rulli, Eliana, Cossu, Antonio, Massi, Daniela, Mandalà, Mario
Published in Cells (2021)

Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) is a novel marker for patients with BRAF-mutated metastatic melanoma

by Audrito, Valentina, Managò, Antonella, Zamporlini, Federica, Rulli, Eliana, Gaudino, Federica, Madonna, Gabriele, D'Atri, Stefania, Antonini Cappellini, Gian Carlo, Ascierto, Paolo Antonio, Massi, Daniela, Raffaelli, Nadia, Mandalà, Mario, Deaglio, Silvia
Published in Oncotarget (2018)

PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p

by Audrito, Valentina, Serra, Sara, Stingi, Aureliano, Orso, Francesca, Gaudino, Federica, Bologna, Cinzia, Neri, Francesco, Garaffo, Giulia, Nassini, Romina, Baroni, Gianna, Rulli, Eliana, Massi, Daniela, Oliviero, Salvatore, Piva, Roberto, Taverna, Daniela, Mandalà, Mario, Deaglio, Silvia
Published in Oncotarget (2017)

SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective study

by Mandala, Mario, Lorigan, Paul, De Luca, Matilde, Bianchetti, Andrea, Merelli, Barbara, Bettini, Anna Cecilia, Bonomi, Lucia, Nahm, Sharon, Vitale, Maria Grazia, Negrini, Giorgia, Di Croce, Andrea, Ascierto, Paolo Antonio, Rulli, Eliana, Tondini, Carlo Alberto
Published in J Immunother Cancer (2021)

KRAS mutations affect prognosis of non-small-cell lung cancer patients treated with first-line platinum containing chemotherapy

by Marabese, Mirko, Ganzinelli, Monica, Garassino, Marina C., Shepherd, Frances A., Piva, Sheila, Caiola, Elisa, Macerelli, Marianna, Bettini, Anna, Lauricella, Calogero, Floriani, Irene, Farina, Gabriella, Longo, Flavia, Bonomi, Lucia, Fabbri, M. Agnese, Veronese, Silvio, Marsoni, Silvia, Broggini, Massimo, Rulli, Eliana
Published in Oncotarget (2015)

A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma

by Gadducci, Angiolo, Grosso, Federica, Scambia, Giovanni, Raspagliesi, Francesco, Colombo, Nicoletta, Grignani, Giovanni, Casali, Paolo, Sanfilippo, Roberta, Buonadonna, Angela, Santoro, Armando, Bruzzone, Milena, Artioli, Grazia, Lorusso, Domenica, Biagioli, Elena, Fossati, Roldano, Galli, Francesca, Negri, Emanuele, Rulli, Eliana, Torri, Valter, D’Incalci, Maurizio
Published in Br J Cancer (2018)

LKB1 mutations are not associated with the efficacy of first-line and second-line chemotherapy in patients with advanced non-small-cell lung cancer (NSCLC): a post hoc analysis of...

by Vernieri, Claudio, Ganzinelli, Monica, Rulli, Eliana, Farina, Gabriella, Bettini, Anna Cecilia, Bareggi, Claudia, Rosso, Lorenzo, Signorelli, Diego, Galli, Giulia, Lo Russo, Giuseppe, Proto, Claudia, Moro, Massimo, Indraccolo, Stefano, Busico, Adele, Sozzi, Gabriella, Torri, Valter, Marabese, Mirko, Massimo, Broggini, Garassino, Marina C.
Published in ESMO Open (2020)

Predicting the Role of DNA Polymerase β Alone or with KRAS Mutations in Advanced NSCLC Patients Receiving Platinum-Based Chemotherapy

by Alvisi, Maria Francesca, Ganzinelli, Monica, Linardou, Helena, Caiola, Elisa, Lo Russo, Giuseppe, Cecere, Fabiana Letizia, Bettini, Anna Cecilia, Psyrri, Amanda, Milella, Michele, Rulli, Eliana, Fabbri, Alessandra, De Maglie, Marcella, Romanelli, Pierpaolo, Murray, Samuel, Ndembe, Gloriana, Broggini, Massimo, Garassino, Marina Chiara, Marabese, Mirko
Published in J Clin Med (2020)

Body mass index (BMI) and outcome of metastatic melanoma patients receiving targeted therapy and immunotherapy: a multicenter international retrospective study

by Rutkowski, Piotr, Indini, Alice, De Luca, Matilde, Merelli, Barbara, Mariuk-Jarema, Anna, Teterycz, Pawel, Rogala, Pawel, Lugowska, Iwona, Cybulska-Stopa, Bożena, Labianca, Alice, Di Guardo, Lorenza, Del Vecchio, Michele, Pigozzo, Jacopo, Randon, Giovanni, Corti, Francesca, Tondini, Carlo Alberto, Rulli, Eliana, Mandala, Mario
Published in J Immunother Cancer (2020)